Utah insurance exchange hacked

Salt Lake City, Utah - 28.31 Kb
The Utah Health Exchange, a state insurance exchange whose development started several years before the healthcare reform law mandated exchanges, was recently hacked, with words garbled, headlines blurred and some pages inaccessible.

The Salt Lake Tribune reported on the hacking and said the site was down for about 10 days. Protected health information is on a separate secure site and was not affected.

The state's Department of Technology services maintains the breached site and also was responsible for the comprehensive hacking of Medicaid data in March. Protected health information was compromised for 780,000 individuals, including up to 280,000 Social Security numbers.

All state exchanges will hold a wealth of personal information but in order for the U.S. Department of Health and Human Services to issue its approval, states must prove they meet five provisions related to privacy and security.

Federal guidance for applications—due Nov. 16—requires that states provide “adequate safeguards” to protect personal information on the exchange. States also must secure a letter of acceptance from the IRS, affirming that they're capable of protecting federal tax information, which will be used to determine eligibility for Medicaid and tax subsidies on the exchanges.

According to the exchange rules, “Personally identifiable information should be protected with reasonable operational, administrative, technical, and physical safeguards to ensure its confidentiality, integrity and availability and to prevent unauthorized or inappropriate access, use or disclosure.”



Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.